Provided by Tiger Trade Technology Pte. Ltd.

BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD

1.30
+0.639996.94%
Post-market: 1.20-0.0954-7.34%19:59 EDT
Volume:142.44M
Turnover:174.38M
Market Cap:1.34M
PE:-0.02
High:1.55
Open:0.8800
Low:0.8342
Close:0.6601
52wk High:59.40
52wk Low:0.6100
Shares:1.03M
Float Shares:943.50K
Volume Ratio:1,179.56
T/O Rate:15096.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-78.3088
EPS(LYR):-67.2947
ROE:-42.00%
ROA:-40.11%
PB:0.10
PE(LYR):-0.02

Loading ...

Why Is Biodexa Pharmaceuticals (BDRX) Stock Skyrocketing Today?

Benzinga_recent_news
·
Apr 03

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live
·
Apr 02

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:34 AM

Reuters
·
Apr 02

Biodexa partners with Syngene to manufacture MTX240 GMP clinical trial supplies

Reuters
·
Apr 02

Biodexa, Tanner Pharma launch global early access program for eRapa in FAP patients

Reuters
·
Apr 01

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
Mar 31

Biodexa Pharmaceuticals FY2025 operating loss narrows 6.02% to £8.6 million; revenue was nil

Reuters
·
Mar 28

European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading

MT Newswires Live
·
Mar 27

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live
·
Mar 26

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading

MT Newswires Live
·
Mar 24

European Equities Traded in the US as American Depositary Receipts Climb in Monday Trading

MT Newswires Live
·
Mar 23

Biodexa partners with Tanner Pharma Group to launch global early access program for eRapa in FAP patients

Reuters
·
Mar 23

Biodexa Pharmaceuticals plc Director Stephen Barry Parker Files Initial Beneficial Ownership Statement

Reuters
·
Mar 21

European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading

MT Newswires Live
·
Mar 19

Biodexa Pharmaceuticals to execute 1-for-5 ADR reverse split on April 6, 2026

Reuters
·
Mar 19

Biodexa Pharmaceuticals CEO and Director Stephen Anthony Stamp files initial beneficial ownership statement

Reuters
·
Mar 18

Biodexa Pharmaceuticals plc director Simon de Vries files initial beneficial ownership statement

Reuters
·
Mar 18

Biodexa Pharmaceuticals plc files initial beneficial ownership statement for CFO and Director Fiona Mary Powell

Reuters
·
Mar 18

European Equities Traded in the US as American Depositary Receipts Higher Monday

MT Newswires Live
·
Mar 16